You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Noema Pharma raises crucial financing for treatments

Noema Pharma – a company targeting debilitating central nervous system disorders – has announced that it has successfully completed a Series B financing round. The company has subsequently raised $112m from new and existing investors.